share_log

HC Wainwright Raises Price Target on Dare Bioscience to $7 From $6, Reiterates Buy Rating

HC Wainwright Raises Price Target on Dare Bioscience to $7 From $6, Reiterates Buy Rating

HC 溫賴特將敢於生物科學的價格目標價格從 6 美元提高到 7 美元,重申購買評級
MT Newswires ·  2022/12/13 07:40

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論